Spectral-domain optical coherence tomography imaging findings in patients receiving teprotumumab for thyroid eye disease

Purpose: Prior studies have demonstrated the potential side effects of insulin-like growth factor-1 (IGF-1) inhibition for thyroid eye disease (TED) including hearing loss. In this study, we assessed changes in functional vision including visual field testing and best-corrected visual acuity (BCVA),...

Full description

Saved in:
Bibliographic Details
Main Authors: Timothy Truong, Rona Z. Silkiss, Johnell Renz Amoroso, Huanye Li, Quan V. Hoang, Kasra Eliasieh, Jesse J. Jung
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:American Journal of Ophthalmology Case Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2451993625000350
Tags: Add Tag
No Tags, Be the first to tag this record!